Olaf Oldenburg Selected Research

Olaf Oldenburg Research Topics

28	Heart Failure 01/2024 - 03/2007
12	Sleep Apnea Syndromes (Sleep Apnea) 11/2017 - 03/2007
12	Cheyne-Stokes Respiration 11/2017 - 01/2011
11	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2021 - 01/2014
11	Apnea 01/2021 - 01/2012
8	Obstructive Sleep Apnea 03/2020 - 01/2014
4	Atrial Fibrillation 01/2019 - 09/2014
3	Hypoxia (Hypoxemia) 07/2021 - 01/2017
3	Infarction (Infarctions) 01/2020 - 06/2003
3	Ventricular Tachycardia 01/2019 - 04/2012
2	Systolic Heart Failure 03/2020 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2016 - 05/2003
2	Hyperventilation 04/2015 - 01/2015
2	Thrombosis (Thrombus) 04/2012 - 12/2002
2	Ischemia 08/2002 - 08/2002
1	Mitral Valve Insufficiency (Mitral Regurgitation) 05/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2021
1	Myocardial Infarction 01/2020
1	Ventricular Fibrillation 01/2019
1	Pulmonary Hypertension 01/2019
1	Atrial Flutter (Flutter, Atrial) 05/2016
1	Cardiac Arrhythmias (Arrythmia) 07/2015
1	Sinus Tachycardia 09/2014
1	Tachycardia (Tachyarrhythmias) 09/2014
1	Hypotension (Low Blood Pressure) 09/2012
1	Ventricular Remodeling 08/2012
1	Chest Pain (Chest Pains) 08/2003
1	Fistula 08/2003
1	Infections 12/2002
1	Orthostatic Hypotension (Postural Hypotension) 12/2002
1	Hematoma 12/2002
1	Hemorrhage 12/2002

3	Oxygen (Dioxygen)IBA 01/2021 - 05/2017
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 05/2013
2	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2021 - 03/2020
2	Carbon DioxideIBA 11/2017 - 04/2015
2	pro-brain natriuretic peptide (1-76)IBA 01/2014 - 06/2008
2	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2003 - 08/2002
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2024
1	ProcollagenIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Collagen Type III (Type III Collagen)IBA 01/2024
1	SodiumIBA 08/2018
1	GasesIBA 11/2017
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2017
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2017
1	Iloprost (Ventavis)FDA Link 05/2016
1	C-Reactive ProteinIBA 01/2014
1	Peptides (Polypeptides)IBA 06/2013
1	Anti-Arrhythmia AgentsIBA 01/2012
1	N- cyano- N'- (1,1- dimethylpropyl)- N''- (3- pyridinyl)guanidineIBA 09/2003
1	5-hydroxydecanoic acidIBA 09/2003
1	ThalliumIBA 08/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2003
1	CholesterolIBA 05/2003
1	hydroxide ionIBA 12/2002
1	Adenosine Triphosphate (ATP)IBA 08/2002

29	Therapeutics 01/2021 - 03/2007
5	Defibrillators (Defibrillator) 01/2019 - 01/2011
5	Cardiac Resynchronization Therapy 09/2014 - 07/2010
2	Continuous Positive Airway Pressure 01/2020 - 12/2018
2	Aftercare (After-Treatment) 02/2018 - 01/2017
1	Critical Care (Surgical Intensive Care) 05/2021
1	Percutaneous Coronary Intervention 01/2020
1	Cardiac Rehabilitation 11/2016
1	Electric Countershock (Cardioversion) 05/2016
1	Mechanical Ventilators (Ventilator) 09/2015
1	Secondary Prevention 07/2015
1	Cardiac Resynchronization Therapy Devices 03/2014
1	Counterpulsation (External Counterpulsation) 06/2012
1	Catheters 08/2003
1	Vascular Surgical Procedures 12/2002